The prognostic significance of ZEB1-AS1 and NUDT3 in CRC patients from the TCGA dataset was confirmed by ROC analysis (training set: 1-year AUC = 0.650, 3-year AUC = 0.706, 5-year AUC = 0.706, Figure 4(e); testing set: 1-year AUC = 0.705, 3-year AUC = 0.592, 5-year AUC = 0.753, Figure 4(f)). This evidence concerns the gene NUDT3 and colorectal carcinoma.